What’s Really Going On With Coronavirus Testing?

Mateusz Slodkowski/ZUMA

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

I complained yesterday about how opaque Deborah Birx was in her discussion of coronavirus testing, and I got some pushback that maybe I didn’t understand all the different kinds of tests she was talking about. Maybe! But here’s the transcript of what Birx said after Chuck Todd played a tape of Bill Gates criticizing our lack of testing capacity. Can you figure it out? My comments are in italics.

BIRX: Uniquely, we are using nucleic acid testing. What does that mean? You are actually sampling for the live virus in people’s noses or in people’s throats. And then you have to expand that doing what we call nucleic acid testing.

Wait. We’re using nucleic acid testing but then we have to expand that by doing what we call nucleic acid testing? My best guess is that she meant to say we’re using PCR testing now and want to expand that to NAT later. Maybe?

So this is not like a flu test or a strep test. So when we talked to the commercial companies almost seven weeks ago, eight weeks ago, we asked every single corporation and every single diagnostic company that had nucleic acid testing capacity on their platforms, which is primarily HIV and HPV, and make tests for those platforms. And in less than two to three weeks, every single one of these platforms are up and running. Etc.

So . . . all these companies are now making NAT testing available for COVID-19?

TODD: Look, the debate about testing, and I know the president gets defensive and claims that testing has been a success story. It does feel as if there is a hesitance to use the Defense Production Act in order, whether it is swabs, whether it is getting these reagents, whether it is forcing these labs to process things faster, guaranteeing some funding for it. Why the hesitance inside that task force?

BIRX: I think all of those pieces are discussed with — inside the task force. From generation of swabs, to generation of tubes and the media. I think what people do not see behind the scenes is how FDA have worked with corporations to really change the number of swabs that can be utilized. If you remember, we — just four weeks ago, we were recommending these nasopharyngeal swabs and we have moved to multiple different swabs, multiple different extraction media. The intent is to continue to scale, with the support of states and working with states, to continue to scale testing. But at the same time, we have to realize that we have to have a breakthrough innovation in testing. We have to be able to detect antigens, rather than constantly trying to detect the actual live virus or the viral particles itself. And to really move into antigen testing. And I know corporations and diagnostics are working on that now. We have to have a breakthrough. This RNA testing will carry us certainly through the spring and summer. But we need to have a huge technology breakthrough. And we are working on that at the same time.

RNA testing? Is this the current generation of PCR testing that she’s talking about? Or is she referring to NAT testing? Or what? And why does she seem to suggest that antigen testing is a replacement for PCR testing? I mean, it could be, but its main purpose is to identify anyone who’s ever had the virus. PCR testing is designed to find out if someone has the virus right now. Birx also says that we’re going to keep scaling up the current testing, but we really need a breakthrough innovation.

TODD: So essentially what you’re saying is we don’t have — you don’t think we have the capacity to ramp up the testing you would like because we need this — we basically need a breakthrough for easier testing?

BIRX: No, I think we have other technology that we think can come online within the next two to three weeks. That will be a breakthrough in the RNA type testing. But I think also just for ease of use, finding out how we can do antigen type testing like they do with flu. It can be used as a screening test. And then you could do the actual RNA testing for a confirmatory test. Just allows you to screen large numbers of individuals quickly.

Now she’s talking about a breakthrough in “RNA testing.” In the next two or three weeks. That sounds interesting! But she never tells us what she’s talking about. And we don’t need a huge breakthrough in antigen testing after all. It would just be nice.

I get that sometimes on live TV you’re not always as clear as you’d like to be. But come on. This stuff isn’t that complicated. Are we ramping up the current generation of PCR testing? Or do we think that’s impossible and we’re waiting for antigen testing to become available? If that’s the case, why is it impossible to ramp up PCR testing? Or is it possible but not in the timeframe we need it? And what are we going to use the $25 billion in test funding for?

Is there someone who can provide us with a simple, one-page fact sheet spelling out our current testing plans? If not, why not? This stuff shouldn’t be done behind closed doors.

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

WE'LL BE BLUNT

It is astonishingly hard keeping a newsroom afloat these days, and we need to raise $253,000 in online donations quickly, by October 7.

The short of it: Last year, we had to cut $1 million from our budget so we could have any chance of breaking even by the time our fiscal year ended in June. And despite a huge rally from so many of you leading up to the deadline, we still came up a bit short on the whole. We can’t let that happen again. We have no wiggle room to begin with, and now we have a hole to dig out of.

Readers also told us to just give it to you straight when we need to ask for your support, and seeing how matter-of-factly explaining our inner workings, our challenges and finances, can bring more of you in has been a real silver lining. So our online membership lead, Brian, lays it all out for you in his personal, insider account (that literally puts his skin in the game!) of how urgent things are right now.

The upshot: Being able to rally $253,000 in donations over these next few weeks is vitally important simply because it is the number that keeps us right on track, helping make sure we don't end up with a bigger gap than can be filled again, helping us avoid any significant (and knowable) cash-flow crunches for now. We used to be more nonchalant about coming up short this time of year, thinking we can make it by the time June rolls around. Not anymore.

Because the in-depth journalism on underreported beats and unique perspectives on the daily news you turn to Mother Jones for is only possible because readers fund us. Corporations and powerful people with deep pockets will never sustain the type of journalism we exist to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we need readers to show up for us big time—again.

Getting just 10 percent of the people who care enough about our work to be reading this blurb to part with a few bucks would be utterly transformative for us, and that's very much what we need to keep charging hard in this financially uncertain, high-stakes year.

If you can right now, please support the journalism you get from Mother Jones with a donation at whatever amount works for you. And please do it now, before you move on to whatever you're about to do next and think maybe you'll get to it later, because every gift matters and we really need to see a strong response if we're going to raise the $253,000 we need in less than three weeks.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate